Abstract
BackgroundTumor microenvironment-associated T cell senescence is a key limiting factor for durable effective cancer immunotherapy. A few studies have demonstrated the critical role of the tumor suppressor TP53-derived p53 isoforms...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have